TY  - BOOK
AU  - Iglesia, Cheryl B
AU  - Siddique, Moiuri
AU  - Zelivianskaia, Anna
TI  - Surgical Outcomes in Benign Gynecologic Surgery Patients during the COVID-19 Pandemic (SOCOVID study)
SN  - 1553-4650
PY  - 2022///
KW  - *COVID-19
KW  - *Pandemics
KW  - Adolescent
KW  - COVID-19 Testing
KW  - Female
KW  - Gynecologic Surgical Procedures/ae [Adverse Effects]
KW  - Humans
KW  - Pregnancy
KW  - Prospective Studies
KW  - Retrospective Studies
KW  - SARS-CoV-2
KW  - Treatment Outcome
KW  - United States/ep [Epidemiology]
KW  - MedStar Washington Hospital Center
KW  - Minimally Invasive Gynecologic Surgery Fellowship
KW  - Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery
KW  - Journal Article
N2  - CONCLUSION: In this large multi-center prospective cohort study of benign gynecologic surgeries, only 1.1% of patients developed a post-operative COVID-19 infection, with 0.3% of infection in the immediate 14-days after surgery. The incidence of post-operative complications was not different in those with and without prior COVID-19 infections. Copyright (c) 2021. Published by Elsevier Inc; DESIGN: Multicenter prospective cohort study SETTING: Ten institutions in the United States PATIENTS: Patients over the age of 18 years who underwent benign gynecologic surgery from July 1, 2020 to December 31, 2020 were included. All patients were followed from the time of surgery until 10 weeks post-operatively. Those with intra-uterine pregnancy or known gynecologic malignancy were excluded; INTERVENTIONS: Benign gynecologic surgery MEASUREMENTS: The primary outcome was the incidence of perioperative COVID-19 infections which was stratified as 1) prior COVID-19 infection, 2) pre-operative COVID-19 infection and 3) post-operative COVID-19 infection. Secondary outcomes included adverse events and mortality following surgery, as well as predictors for post-operative COVID-19 infection. If surgery was delayed due to the COVID-19 pandemic, the reason for postponement and any subsequent adverse event was recorded; MAIN RESULTS: Of 3423 patients included for final analysis, 189 (5.5%) postponed their gynecologic surgery during the pandemic. Forty-three patients (1.3% of total cases) were due to a history of COVID-19. The majority (182 [96.3%]) had no sequelae attributed to surgical postponement. Following hospital discharge to 10 weeks post-operatively, 39 (1.1%) patients became infected with SARS-CoV-2. The mean duration of time between hospital discharge and the follow-up positive COVID-19 test was 22.1 +/- 12.3 days (range 4-50 days). Eleven (31.4% of post-operative COVID-19 infections, 0.3% of total cases) of the newly diagnosed COVID-19 infections occurred within 14 days of hospital discharge. On multivariable logistic regression, living in the Southwest (adjOR 6.8) and single-unit increase in age-adjusted Charlson co-morbidity index (adjOR 1.2) increased the odds of post-operative COVID-19 infection. Peri-operative complications were not significantly higher in patients with a history of prior positive COVID-19 compared to those without a history of COVID-19, though the mean duration of time between prior COVID-19 diagnosis and surgery was 97 days (14 weeks); STUDY OBJECTIVE: To determine the incidence of perioperative COVID-19 in women undergoing benign gynecologic surgery, and to evaluate perioperative complication rates in patients with active, prior or no prior SARS-CoV-2 infection
UR  - https://dx.doi.org/10.1016/j.jmig.2021.08.011
ER  -